The world' poorest diabetes patients have billions to save and better every-day lives ahead of them, if the ambitions and dreams of the former Novo Nordisk Project Director Ole Kjerkegaard Nielsen and his partner Michael Ejstrup Hansen come to fruition.
Kjerkegaard Nielsen and Ejstrup head the company Go-Pen, which will revolutionize the market for insulin pens.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.